Leaders from Haid Group and Nature Group Visited Fangtong

On June 26, 2026, a delegation of senior leaders and experts from Haid Group and Natur Group visited Fangtong for inspection and guidance. Ms. Liu Lixia, Deputy General Manager of Fangtong, together with senior management and heads of relevant departments, extended a warm welcome to the delegation. The two sides engaged in in-depth discussions on key topics including industry upgrading, quality supervision, food safety, and technological innovation.

At present, the livestock and veterinary pharmaceutical industry is accelerating its pace of quality improvement and upgrading. The growing trend toward industry standardization and normalized development has imposed higher requirements on production, R&D, quality control, and regulatory compliance. Meanwhile, the Ministry of Agriculture and Rural Affairs continues to refine the regulatory framework for veterinary drugs, tightening oversight across the entire chain of production, testing, and distribution, with strict implementation of GMP production standards, quality traceability, and risk prevention mechanisms, requiring enterprises to firmly uphold compliance bottom lines. Furthermore, with rising societal demands for food safety, veterinary drugs—being a critical source input for animal-derived food—have their quality, safety, efficacy stability, and residue controllability directly linked to the safety of livestock products and public health. Strengthening the quality defense line of veterinary drugs has therefore become a core responsibility for animal health enterprises.

During the symposium, Deputy General Manager Ms. Liu provided a detailed overview of Fangtong’s development profile, core products, technological R&D capabilities, and domestic and international market presence. She noted that over the past two decades, Fangtong has remained deeply committed to the animal health sector, consistently aligning itself with high-quality industry development trends, the latest regulatory requirements of the Ministry of Agriculture and Rural Affairs, and high food safety standards, guided by the operating philosophy of "Fangtong builds excellence; innovation creates brilliance." To date, Fangtong operates 11 production lines, covering 21 dosage forms and over 300 product offerings, which are sold widely across China and in more than 30 countries and regions worldwide.

Backed by solid operational strength and superior product quality, Fangtpong has been honored with municipal science and technology progress awards, quality awards, foreign trade and export awards, and the national "May Day Labor Award." It has also been recognized as a national-level High-Tech Enterprise, a Chongqing "Specialized and Sophisticated" Enterprise, a Technological Innovation Demonstration Enterprise, an Outstanding Private Enterprise of Chongqing, and a "Gazelle Enterprise," among other qualifications. Fangtong hosts the Chongqing Municipal Veterinary Pharmaceutical Engineering Technology Research Center and is classified as a Category A Customs Declarer by the People's Republic of China Customs. The Company consistently prioritizes product quality and therapeutic efficacy, strictly adhering to GMP standards throughout the entire production process, and resolutely preventing any substandard products from entering the market, thereby safeguarding breeding safety and food safety at the source.

Following the symposium, the visiting leaders conducted on-site inspections of Fangtong's intelligent production workshops, logistics and warehousing center, and the Veterinary Pharmaceutical Engineering Technology R&D Center. Through detailed staff presentations, they gained comprehensive insights into Fangtong's production scale, automated manufacturing processes, end-to-end quality control measures, warehousing management, R&D equipment configuration, scientific innovation initiatives, and the meticulous implementation of GMP practices, offering them a direct and vivid demonstration of Fangtong's standardized and integrated production and operation model.

The delegation highly commended Fangtong's advanced production techniques, rigorous quality control systems, and robust R&D capabilities, recognizing that Fangtong's business philosophy and development model are closely aligned with the prevailing trends of high-quality industry development, compliance-driven regulation, and food safety traceability in the current animal health sector.

Fangtong stated that, going forward, it will continue to closely follow new industry developments, fully implement the quality supervision requirements set forth by the Ministry of Agriculture and Rural Affairs, uphold the bottom line of food safety, intensify investment in scientific and technological innovation, optimize production processes and quality control systems, and deepen its commitment to the R&D and promotion of animal health products. With over two decades of steady development, Fantong has achieved sustained growth and maturity. Looking ahead, it looks forward to deepening collaboration with major livestock farming groups, pursuing win-win partnerships, and contributing to the high-quality development of the livestock and breeding industry.